About BioTek
BioTek is a publicly listed company based in Winooski (United States) founded in 1993, and was acquired by Agilent in July 2019. Instrumentation and software for microplate-based in-vitro assays are provided. Its chief executive, as recorded, is Briar Alpert. Its Indian entity Biospec Private Limited reported revenue of ₹1.44 Cr. BioTek offers products and services including Chromatography Systems, Mass Spectrometry, and Microplate Instrumentation. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Assays and Cell Based Assays. Its competitors include Lucid Scientific, Kiyatec and CytoTronics; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 1993 and headquartered in Winooski, United States, BioTek focuses on the life sciences sector. Imaging systems, detection instruments, liquid handling tools, robotics, and software for microplate-based in vitro assays are developed and manufactured. Products include automated cell imagers like Lionheart FX, multi-mode readers such as Cytation, washers, dispensers, stackers, and Gen5 software. Applications span cellular and cell-free assays in research settings.
Associated legal entities of BioTek
BioTek operates through Biospec Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Biospec Private Limited CIN U72900MH2007PTC171963 | Active | 25 Jun 2007 | Mumbai, Maharashtra | ₹1.4 Cr | 2 | View details |
Products & Services of BioTek
BioTek offers a comprehensive portfolio of products and services, including Chromatography Systems, Mass Spectrometry, and Microplate Instrumentation.
Equipment for separating chemical mixtures in laboratories.
Tools for identifying molecules in research applications.
Devices for cell analysis and high-throughput screening.
Apps and channels of BioTek
its YouTube channel Agilent Technologies has 42K subscribers and 30 videos.
Videos from BioTek
The most watched videos on BioTek's YouTube channel, Agilent Technologies (42K subscribers). Click a video to play it here.
More on Agilent Technologies.
Investors in BioTek
BioTek has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Agilent.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diversified instruments are developed for scientific and laboratory management. | 1995 | agilent.com | Santa Clara, United States |
Investor details for BioTek
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Biospec Private Limited (BioTek)
Biospec Private Limited is the primary company behind BioTek. The board of Biospec Private Limited currently have 2 directors; the longest-serving is Vipul Kalyanji Chhatbar, appointed in 2007.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vipul Kalyanji Chhatbar DIN 00303376 | Director | 25 Jun 2007 | 19 yrs 4 mo | Biospec Private Limited |
| Nikita Vipul Chhatbar DIN 00303497 | Director | 25 Jun 2007 | 19 yrs 4 mo | Biospec Private Limited |
People of BioTek
1 people are tracked at BioTek (1 in leadership).
| Name | Role | Group |
|---|---|---|
Briar Alpert | CEO & President | Leadership |
Complete people profiles for BioTek
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of BioTek
BioTek is a publicly listed company on the KRX with ticker symbol 270210 in South Korea, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date15 Jun 2017
- Listed onKRX: 270210
- Listed entitySR Biotek, Inc.
- Exchange sectorConsumer non-durables
- ISINKR7270210008
- Share price10,940.00 KRW (-0.45% on the day) · 2026-10-14
- Market capitalisation18,808,813,016.00 KRW
- Volume (last session)64
Financials of BioTek
Figures of Biospec Private Limited, the primary company behind BioTek, for FY 2024. Revenue was ₹1.44 Cr (+2360% year on year). Net profit was ₹24.9 Lakh (17% margin). EBITDA was ₹34 Lakh (24% margin). Revenue has grown at a compounded annual rate of +93% over three years and +73% over five years.
- ₹1.44 CrRevenue · FY 2024 · +2360% YoY
- ₹24.9 LakhNet profit · 17% margin
- ₹34 LakhEBITDA · 24% margin
- ₹1 LakhPaid-up capital
- +93%Revenue CAGR, 3 years
- +73%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 37.43B KRW | 3.27B KRW | 2.88B KRW |
| 2024 | 29.45B KRW | 1.65B KRW | 1.85B KRW |
| 2023 | 8.17B KRW | -1.53B KRW | -1.35B KRW |
| 2022 | 7.41B KRW | -956.9M KRW | -788.1M KRW |
| 2021 | 5.68B KRW | -545.7M KRW | -426.8M KRW |
Balance sheet, profit and loss, cash flow and ratios of Biospec Private Limited are on its company page.
Detailed financial statements for BioTek
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of BioTek
3 dated milestones of BioTek across 26 years, from founding to its latest funding, stage changes and deals.
- Founded BioTek is founded.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Agilent.
Competitors of BioTek
BioTek has 3 listed competitors in our database, 3 of them funded. They include Lucid Scientific, Kiyatec and CytoTronics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lucidsci.com | 2012 | Atlanta, United States | $12.73M | Real-time cell analyzers are developed for oxygen consumption monitoring. | ||
| kiyatec.com | 2005 | Pendleton, United States | $29.49M | Kiyatec is focused on revolutionizing cancer care through predictive platforms. | ||
| cytotronics.com | 2015 | Boston, United States | $22.75M | 22 | Cell-based assays for drug discovery are developed via CMOS platform. |
Detailed competitors of BioTek
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of BioTek
Websites that share an audience with BioTek (biotek.com).
Websites whose visitors overlap most with BioTek. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| moleculardevices.com | 100% | 131.7K | #329,224 | View details | |
| labcyte.com | 91% | View details | |||
mobitec.de | mobitec.de | 84% | – | ||
| hudsonrobotics.com | 79% | View details | |||
promega.com | promega.com | 74% | #192,389 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 14 similar websites and full traffic analytics for BioTek
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 14 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as BioTek (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Biotek
Complete news archive for BioTek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BioTek
BioTek was founded in 1993.
BioTek is headquartered in Winooski, United States. It is registered at Winooski, Vermont, United States.
Briar Alpert is the CEO of BioTek, as recorded in our data.
The primary company behind BioTek, Biospec Private Limited, reported revenue of ₹1.44 Cr for FY 2024, up 2360% year on year.
Founded in 1993 and headquartered in Winooski, United States, BioTek focuses on the life sciences sector. Imaging systems, detection instruments, liquid handling tools, robotics, and software for microplate-based in vitro assays are developed and manufactured. Products include automated cell imagers like Lionheart FX, multi-mode readers such as Cytation, washers, dispensers, stackers, and Gen5 software. Applications span cellular and cell-free assays in research settings.
BioTek's top competitors include CytoTronics, Kiyatec and Lucid Scientific.
BioTek offers Chromatography Systems, Mass Spectrometry, and Microplate Instrumentation.
Yes, BioTek is publicly traded on KRX under the ticker symbol 270210.
BioTek has 1 investor. Key investors include Agilent.
BioTek operates through Biospec Private Limited.
Yes. BioTek was acquired by Agilent in July 2019.
The legal entities of BioTek currently have 2 directors, including Vipul Kalyanji Chhatbar, Nikita Vipul Chhatbar.